QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
1-Year Est. Return
18.39%
1 Year Est. Return
-18.39%
AUM
$23.6M
AUM Growth
+$513K
(+2.2%)
Holding
6
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tourmaline Bio
TRML
$1.23B
| $11.9M | 50.22% |
741,691
|
|
||
2
Jasper Therapeutics
JSPR
$68.4M
| $5.16M | 21.83% |
928,964
|
|
||
3
Korro Bio
KRRO
$396M
| $4.6M | 19.47% |
368,085
|
|
||
4
Ventyx Biosciences
VTYX
$280M
| $882K | 3.74% |
412,225
|
|
||
|
HLVX
5
DELISTED
HilleVax
HLVX
| $742K | 3.14% |
372,615
|
|
||
6
Kezar Life Sciences
KZR
$46.6M
| $380K | 1.61% |
82,871
|
|